These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24519932)

  • 1. Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis.
    DeBosch BJ; Chen Z; Saben JL; Finck BN; Moley KH
    J Biol Chem; 2014 Apr; 289(16):10989-10998. PubMed ID: 24519932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.
    Lee H; Kim E; Shin EA; Shon JC; Sun H; Kim JE; Jung JW; Lee H; Pinanga Y; Song DG; Liu KH; Lee JW
    Mol Metab; 2022 Apr; 58():101451. PubMed ID: 35123128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
    DeBosch BJ; Chen Z; Finck BN; Chi M; Moley KH
    Mol Endocrinol; 2013 Nov; 27(11):1887-96. PubMed ID: 24030250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization.
    DeBosch BJ; Chi M; Moley KH
    Endocrinology; 2012 Sep; 153(9):4181-91. PubMed ID: 22822162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy.
    Mayer AL; Higgins CB; Heitmeier MR; Kraft TE; Qian X; Crowley JR; Hyrc KL; Beatty WL; Yarasheski KE; Hruz PW; DeBosch BJ
    Sci Rep; 2016 Dec; 6():38586. PubMed ID: 27922102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Hepatic PPARα Activity Links GLUT8 Deficiency to Augmented Peripheral Fasting Responses in Male Mice.
    Mayer AL; Zhang Y; Feng EH; Higgins CB; Adenekan O; Pietka TA; Beatty WL; DeBosch BJ
    Endocrinology; 2018 May; 159(5):2110-2126. PubMed ID: 29596655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation.
    Novelle MG; Bravo SB; Deshons M; Iglesias C; García-Vence M; Annells R; da Silva Lima N; Nogueiras R; Fernández-Rojo MA; Diéguez C; Romero-Picó A
    iScience; 2021 Feb; 24(2):102071. PubMed ID: 33554072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    Sodhi K; Puri N; Favero G; Stevens S; Meadows C; Abraham NG; Rezzani R; Ansinelli H; Lebovics E; Shapiro JI
    PLoS One; 2015; 10(6):e0128648. PubMed ID: 26098879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
    Gugliucci A
    Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
    Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
    J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8.
    Corpe CP; Eck P; Wang J; Al-Hasani H; Levine M
    J Biol Chem; 2013 Mar; 288(13):9092-101. PubMed ID: 23396969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
    Ouyang X; Cirillo P; Sautin Y; McCall S; Bruchette JL; Diehl AM; Johnson RJ; Abdelmalek MF
    J Hepatol; 2008 Jun; 48(6):993-9. PubMed ID: 18395287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.
    Green CJ; Johnson D; Amin HD; Sivathondan P; Silva MA; Wang LM; Stevanato L; McNeil CA; Miljan EA; Sinden JD; Morten KJ; Hodson L
    Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E511-22. PubMed ID: 26126685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.